Data / Federal awards / NAICS 541715 / A&G PHARMACEUTICAL, INC.
A&G PHARMACEUTICAL, INC.: 15 federal contract awards, $91,112 obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
A&G PHARMACEUTICAL, INC. (UEI SN6SWFABJXL1), Columbia, MD, received 15 federal prime contract awards with $91,112 obligated in fiscal years 2024 to 2027, from 1 agency under 7 NAICS codes. Its largest buyer is Department of Health and Human Services ($91,112) and its largest code is NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The request: Every federal contract awarded under NAICS 541715, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- SN6SWFABJXL1
- Location
- Columbia, MD
- Business size
- Other Than Small Business
- Contract awards
- 15
- Obligated
- $91,112
- First action in window
- 2024-01-30
- Latest action
- 2026-08-26
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 5 | $102,914 |
| 325998 | All Other Miscellaneous Chemical Product and Preparation Manufacturing | 1 | $13,600 |
| 325414 | Biological Product (except Diagnostic) Manufacturing | 2 | $2,114 |
| 325412 | Pharmaceutical Preparation Manufacturing | 3 | $-1,639 |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 1 | $-5,604 |
| 541380 | Testing Laboratories and Services | 2 | $-7,725 |
| 541690 | Other Scientific and Technical Consulting Services | 1 | $-12,548 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 15 | $91,112 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $93,920 |
| FY2025 | $24,896 |
| FY2026 | $-27,704 |
Contract awards
All 15 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541715 | TASK ORDER 7 - DOK7 | $105,670 | $105,670 | March 18, 2024 | March 17, 2025 | Rockville, MD | usaspending.gov |
| 75N95022F00001 | Department of Health and Human Services | Delivery Order | 541715 | POLYCLONAL RAT ANTIBODY AND MONOCLONAL RAT ANTIBODIES AGAINST GLYCOL-CHITOSAN NANOPARTICLES | $35,421 | $83,401 | June 30, 2022 | March 31, 2025 | Rockville, MD | usaspending.gov |
| 75N93025P00729 | Department of Health and Human Services | Purchase Order | 325414 | MONOCLONAL ANTIBODY AGAINST MARCH1 PREPARATION MAB-P3-00-001, 002, 003, 005 AND MAB-P3-HC-001 (AMBIS #2254762) | $16,900 | $16,900 | March 25, 2025 | July 31, 2025 | Columbia, MD | usaspending.gov |
| 75N95023F00001 | Department of Health and Human Services | Delivery Order | 541715 | TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ | $16,463 | $132,863 | September 1, 2023 | August 31, 2024 | Rockville, MD | usaspending.gov |
| 75N93024P01059 | Department of Health and Human Services | Purchase Order | 541380 | PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONING | $15,500 | $15,500 | August 27, 2024 | November 30, 2024 | Columbia, MD | usaspending.gov |
| 75N95C25P00114 | Department of Health and Human Services | Purchase Order | 325998 | TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT. | $13,600 | $13,600 | September 24, 2025 | September 23, 2026 | Columbia, MD | usaspending.gov |
| 75N95018D00010 | Department of Health and Human Services | IDC | 541715 | REAGENT GENERATION FOR BIOANALYTICAL METHOD DEVELOPMENT FOR BIOLOGICS | $0 | $696,028 | June 6, 2018 | usaspending.gov | ||
| 75N98024A00057 | Department of Health and Human Services | BPA | 325412 | O/M ITEMS ONLY: BIOLOGICAL MATERIALS, LABORATORY & TESTING SERVICES, ANIMAL TESTING SERVICES | $0 | $0 | January 30, 2024 | usaspending.gov | ||
| 75N95D19P00216 | Department of Health and Human Services | Purchase Order | 325412 | A&G PHARMACEUTICAL INC:1108556 [19-012467]MONOCLONAL ANTIBODY (MAB) DEVELOPMENT | $-787 | $14,630 | September 13, 2019 | January 26, 2020 | Columbia, MD | usaspending.gov |
| 75N95D19P00219 | Department of Health and Human Services | Purchase Order | 325412 | A&G PHARMACEUTICAL INC:1108556 [19-012522] | $-852 | $23,087 | September 16, 2019 | January 20, 2020 | Columbia, MD | usaspending.gov |
| 75N91020P00499 | Department of Health and Human Services | Purchase Order | 541714 | NIH-APPROVED COVID-RELATED PROJECT: ANALYSIS OF A NOVEL TRUNCATED FORM OF ACE2 RECEPTOR | $-5,604 | $19,350 | June 18, 2020 | June 19, 2020 | Columbia, MD | usaspending.gov |
| 75N91019P00615 | Department of Health and Human Services | Purchase Order | 541690 | PRODUCTION OF MULTIPLE MONOCLONAL ANTIBODIES | $-12,548 | $0 | August 1, 2019 | August 30, 2024 | Columbia, MD | usaspending.gov |
| 75N93019P01122 | Department of Health and Human Services | Purchase Order | 325414 | MONOCLONAL ANTIBODY PRODUCTION OF PVS230 | $-14,786 | $0 | August 30, 2019 | April 3, 2024 | Bethesda, MD | usaspending.gov |
| 75N93021P01162 | Department of Health and Human Services | Purchase Order | 541380 | ANTIBODY DEVELOPMENT SERVICES FOR MALARIAL ORGANELLES | $-23,225 | $0 | August 16, 2021 | December 31, 2021 | Columbia, MD | usaspending.gov |
| 75N95019F00088 | Department of Health and Human Services | Delivery Order | 541715 | GENERATING DRUG SPECIFIC MONOCLONAL ANTIBODIES AGAINST TTHX1114, AN ENGINEERED MUTANT HUMAN FGF1 | $-54,639 | $50,209 | September 24, 2019 | June 30, 2020 | Columbia, MD | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- All recipients under NAICS 325414 Biological Product (except Diagnostic) Manufacturing
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 325998
- Open opportunities under NAICS 325414
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.